Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sellers Take Control—Will Pi Coin Fall Back Into Another Sideways Phase?

Sellers Take Control—Will Pi Coin Fall Back Into Another Sideways Phase?

BeInCryptoBeInCrypto2025/11/04 23:00
By:Aaryamann Shrivastava

Pi Coin’s momentum is fading as capital outflows rise and technical signals turn bearish, with the price now at risk of reentering a consolidation zone under $0.20.

Pi Coin has struggled to maintain its late-October recovery momentum, with the altcoin facing renewed selling pressure this week.

The ongoing decline has erased a significant portion of recent gains as market uncertainty combines with investor hesitation. Both external market conditions and internal investor sentiment appear to be driving this downward trajectory.

Pi Coin Outflows Rise

The Chaikin Money Flow (CMF) indicator shows that Pi Coin investors are actively pulling capital out of the market. Currently sitting at a near two-month low and below the neutral zero line, the indicator suggests that outflows are dominating. This signals that investors may be booking profits and reducing exposure amid a slowing recovery.

This shift in sentiment has weakened Pi Coin’s short-term outlook, reflecting waning confidence among holders. The persistent selling pressure indicates that participants are opting for caution over speculation. Unless inflows return, the probability of a sustainable rebound appears limited as liquidity continues to drain from the market.

Want more token insights like this? Sign up for Editor Harsh Notariya’s Daily Crypto Newsletter.

Sellers Take Control—Will Pi Coin Fall Back Into Another Sideways Phase? image 0Pi Coin CMF. Source:  TradingView

From a broader perspective, Pi Coin’s momentum appears to be leaning bearish. The Moving Average Convergence Divergence (MACD) indicator is on the verge of confirming a bearish crossover. The signal line is nearing the MACD line (blue), suggesting a potential shift from neutral to negative momentum in the coming sessions.

Historically, such crossovers have triggered notable corrections for Pi Coin. The impending signal highlights increasing downside risks, as market conditions continue to favor sellers over buyers.

Sellers Take Control—Will Pi Coin Fall Back Into Another Sideways Phase? image 1Pi Coin MACD. Source:  TradingView

PI Price May Slide Further

Pi Coin’s price has declined by nearly 15% over the past week after failing to breach the $0.260 resistance. At the time of writing, the altcoin is trading at $0.220, reflecting its weakening technical position amid fading market support and declining investor optimism.

If the downward trend persists, Pi Coin’s price could fall below $0.209 and reenter a consolidation zone between $0.209 and $0.198. This pattern, seen previously, could stall recovery attempts and extend the bearish phase for a few more weeks.

Sellers Take Control—Will Pi Coin Fall Back Into Another Sideways Phase? image 2Pi Coin Price Analysis. Source:  TradingView

However, a bounce from current levels could shift momentum. If Pi Coin reclaims $0.229 as support, it could attempt a rally toward the $0.246 resistance. Sustaining inflows and investor interest will be critical to invalidating the bearish outlook.

Read the article at BeInCrypto
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window

The FDA will intensively decide on several new drugs in the next two weeks: GSK's functional cure therapy for hepatitis B, Inovio's rare disease therapy, Agios's new drug for sickle cell disease, and Sun Pharma's application for expanded indications.

智通财经•2026/10/19 11:37
GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window

After the Philadelphia Semiconductor Index and Nasdaq plunged, Morgan Stanley called to "get ready to increase positions"

Michael Wilson from Morgan Stanley stated that as the significant correction trajectory in most stock markets over the past few months is about to end, investors should be prepared to increase the risk exposure in their portfolios.

智通财经•2026/10/19 11:18

Roadster is just an appetizer? Renowned investor predicts: SpaceX (SPCX.US) may announce the acquisition of Tesla (TSLA.US) within weeks at $420 per share

Gary Black, Managing Director of the Future Fund, recently tweeted a prediction that SpaceX may announce an all-stock acquisition of Tesla within weeks and view the launch of the flying edition Roadster as an opportunity to integrate Elon Musk's companies.

智通财经•2026/10/19 11:13